Microdosing

Understanding How Microdosing Might Work in the Brain

The mechanisms behind how microdosing affects the brain remain largely unknown. While microdosing is popular and many report positive experiences, scientific evidence about its efficacy is limited. For example, one recent study, which has faced criticism for its methodology, suggested that microdosing may not be more effective than a placebo. However, some researchers, like Dr. James Fadiman, believe that microdosing might work similarly to larger doses of psychedelics. Let's delve into some theories.

How Psychedelics Work at Larger Doses

When psychedelics like LSD or psilocybin are taken in large doses, they primarily interact with the 5-HT2A serotonin receptors in the brain. These receptors are dispersed throughout the brain but are most concentrated in the prefrontal cortex. The prefrontal cortex is responsible for critical functions such as planning, decision-making, aspects of speech and language, executive functions, and short-term memory. Essentially, it helps people set and achieve goals.

When psychedelics bind to the 5-HT2A receptors in the prefrontal cortex, they reduce neural activity in that area. Less activity in the prefrontal cortex means that certain filters and barriers in the brain are lowered. This can lead to an altered state of consciousness and may explain why psychedelics are being explored in research on various psychological patterns. Psychedelic experiences may help people gain new perspectives on their problems, allowing them to process emotions and experiences in novel ways.

The Role of the Default Mode Network (DMN)

The default mode network (DMN) is a network of brain regions that becomes active when the mind is at rest and not focused on the outside world. It is engaged in activities like daydreaming, recalling memories, and planning for the future. An overactive DMN is often associated with negative mental states such as depression and anxiety, as it keeps the mind occupied with self-referential thoughts, often leading to rumination and worry.

Psychedelics are thought to reduce activity in the DMN, which may explain their reported positive effects. By quieting the DMN, psychedelics could help reduce the excessive self-focus and rumination that characterizes many mental health conditions. Reduced DMN activity might enable the brain to establish new communication patterns, potentially leading to long-term improvements in mood and cognition.

Microdosing and Its Hypothesized Effects

While the exact mechanisms of microdosing are still unclear, Dr. James Fadiman suggests that it might impact the brain similarly to larger doses by stimulating the 5-HT2A receptors. However, there are significant limitations to this hypothesis. Firstly, no brain imaging studies have been conducted on individuals who microdose. Secondly, even if microdosing affects the brain in the same way as macrodosing, the precise workings of macrodosing are still not fully understood.

Despite these limitations, many people report positive experiences with microdosing, and more research is being conducted to better understand its effects. It is possible that even small doses of psychedelics can influence serotonin pathways in a way that benefits mood, focus, and creativity, though more studies are needed to confirm these effects.

Insights from Research and Citizen Science

A comprehensive review of microdosing research was conducted by Kim Kuypers from Maastricht University, who analyzed 14 experimental studies on microdosing. These studies involved working with low doses of LSD (10-20 micrograms) or psilocybin (less than 1-3 mg) to both healthy volunteers and participants with clinical conditions. Kuypers found that microdosing had subtle positive effects on cognitive processes and brain regions related to emotions. However, increased anxiety and fluctuations between positive and negative emotions were also noted.

Kuypers concluded that while low doses of psychedelics might influence cognitive and emotional processes, more rigorous studies are needed to definitively assess microdosing's potential. She emphasized that although there is preliminary evidence that microdosing can affect cognition and emotions, the clinical relevance of these effects is still uncertain.

The Growing Data on Microdosing

The largest citizen science database on microdosing was, for many years, Dr. Fadiman's survey. Recently, however, a new study led by the University of British Columbia, the Multidisciplinary Association for Psychedelic Studies (MAPS), and Quantified Citizen, an app for citizen science, has collected over 13,000 reports on microdosing. Although the data has not yet been released, Paul Stamets, who collaborated on the study, has indicated that the results are promising.

Despite the need for more comprehensive research, the growing body of anecdotal evidence, coupled with emerging data from citizen science projects, suggests that microdosing may offer various benefits. As the legal landscape continues to evolve and funding for psychedelic research increases, we can expect to see more robust studies that will help us understand how microdosing works and its potential to support mental health and wellbeing.

Note: Psychedelic retreats do not replace medical or psychotherapeutic treatment.